"From Drowning to Treading Water": Adolescents and Young Adults Living with Incurable and Indolent Metastatic Soft Tissue Sarcoma for More than Two Years
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Jan 2025 · 1 min read
In brief
In brief
This pilot study examines the clinical characteristics and lived experiences of adolescents and young adults with incurable metastatic soft tissue sarcoma who survived beyond two years. Using PROMIS questionnaires and qualitative analysis, researchers explore quality of life and develop a conceptual framework for understanding long-term survival in this rare population.
Written by the GCMD Library team from the article.
Statements in this article
Adolescent and young adult patients with metastatic soft tissue sarcoma typically face a dismal prognosis.
A subset of patients with incurable metastatic soft tissue sarcoma lives beyond two years.
More patients with metastatic soft tissue sarcoma are anticipated to experience prolonged survival with the use of targeted or immune therapies.
Patients with metastatic incurable soft tissue sarcoma, aged 15-39 years at diagnosis, and at least two years from diagnosis were eligible for this study.
Patients were recruited over a two-year period at a quaternary children's hospital with a comprehensive adolescent and young adult oncology program.